Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc. is a monoclonal Antibody, Small Molecule founded in 2019.
2
Funding Rounds
$65.4m
Money raised
Overview
Bluejay Therapeutics, Inc. is a monoclonal Antibody, Small Molecule founded in 2019.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Na*** A Ho** | - | - | linkedin twitter |
Funding series
Funding Series Analysis
The company Bluejay Therapeutics, Inc. has raised a total of $41.15m in funding over 2 rounds.
Key Insights:
- Bluejay Therapeutics, Inc. Funding Round, August 2022: $41.15m
- Bluejay Therapeutics, Inc. funding round, June 2021: $24.24m
Bluejay Therapeutics, Inc. Funding Round, August 2022
$41.15m
Bluejay Therapeutics, Inc. funding round, June 2021
$24.24m
Industries
Bluejay Therapeutics, Inc. is active in the following industries:
- Biotechnology